Cancer - Multi-Cancer Early Detection (MCED)
Multi-Cancer Early Detection (MCED)
Detect Multiple Types of Cancer from a Single Blood Test
CancerScreenDx Multi-Cancer Early Detection (MCED) is an advanced blood-based screening test designed to detect cancer signals across more than 110 types of cancer, including many cancers that currently have no routine screening options. The test analyzes circulating tumor DNA (ctDNA) found in the bloodstream and can help identify potential cancer signals before symptoms appear. Unlike traditional cancer screening methods that focus on a single cancer type, MCED provides a broader approach to early cancer detection through a simple blood draw.
Over 110 types
of cancer detected
Non-invasive
blood test
Tissue-of-origin
prediction
Results in
7-14 working days
ISO 15189
certified laboratory
Supports proactive
preventive healthcare
One simple
blood sample required
Powered by
BGI Genomics expertise
Strictly
confidential process
Important: MCED is a screening test and is not intended to diagnose cancer.
Who May Benefit From MCED?
MCED may be particularly beneficial for:
Adults aged 40 and above
Individuals with a family history of cancer
Individuals with a personal history of cancer
People seeking a more proactive approach to preventive healthcare
Individuals looking for broader cancer screening beyond conventional methods
Who May Benefit From MCED?
MCED may be particularly beneficial for:
Adults aged 40 and above
Individuals with a family history of cancer
Individuals with a personal history of cancer
People seeking a more proactive approach to preventive healthcare
Individuals looking for broader cancer screening beyond conventional methods
How does the process work?
How Does MCED Work?
Simple, non-invasive, and confidential from booking to result release.
Book Your Test
Schedule your appointment with our team.
Blood Sample Collection
A simple, non-invasive blood sample is collected. Collection options may include collection centers nationwide and mobile home service in selected areas.
Laboratory Analysis
Cancer cells release small fragments of DNA into the bloodstream, known as circulating tumor DNA (ctDNA). CancerScreenDx analyzes these DNA fragments and looks for patterns associated with cancer.
Receive Your Results
When a cancer signal is identified, the test can estimate the most likely tissue or organ where the signal originated.
Benefits Of MCED
Why Choose Multi-Cancer Early Detection?
Comprehensive Cancer Screening
Detect cancer signals across a broad range of cancer types through a single blood sample.
Non-Invasive
No scans, no scopes, and no surgical procedures. The test requires only a blood draw.
Tissue-of-Origin Prediction
If a cancer signal is detected, the test can help predict the most likely location of the cancer, assisting healthcare providers in determining appropriate follow-up investigations.
Fast Results
Results are typically available within 7-14 working days after sample receipt.
Screen for More Than 110 Types of Cancer
CancerScreenDx can detect signals associated with over 110 different cancer types, including lung, breast, colorectal, ovarian, pancreatic, liver, prostate, cervical, thyroid, kidney cancers, lymphoma, melanoma, and brain cancer.
Early Detection Saves Lives
Detecting cancer signals earlier may help improve health outcomes.
Many cancers are often diagnosed only when symptoms develop or when the disease has already progressed. Early detection can improve treatment options and health outcomes by identifying potential cancer signals at an earlier stage.
And Many Others
MCED provides broader cancer screening coverage beyond conventional single-cancer screening methods.
Important Information
MCED is a screening test and not intended to diagnose cancer
A positive result indicates that a cancer signal may be present and should be followed by appropriate diagnostic testing as recommended by a healthcare professional.
Positive Result
If A Signal Is Detected
A positive result should be followed by appropriate diagnostic testing to confirm diagnosis and guide treatment planning.
Negative Result
If No Signal Is Detected
A negative result does not completely rule out cancer. Routine cancer screening should still be continued according to medical guidelines.
Clinical Guidance
Always interpret MCED results with your healthcare provider
MCED is a screening tool and should be used alongside clinical evaluation and standard guideline-based cancer screening.
Positive results require diagnostic follow-up
Negative results do not completely rule out cancer
Continue routine cancer screening per medical guidelines
Use results to inform next-step discussions with your doctor
Powered By BGI Genomics
Global genomics leadership with trusted local delivery
Lablog partners with BGI Genomics, a global leader in genomics and precision medicine. Every sample is processed through our ISO 15189 certified partner laboratory following strict international laboratory standards and quality assurance protocols.
Advanced genomic technology and ctDNA analysis
ISO 15189 certified partner laboratory
Strict international standards and quality assurance
Accessible and trusted service throughout the Philippines
Safe, Private & Confidential
We understand that health information is deeply personal. Every sample, report, and patient record is handled with strict confidentiality and released only to authorized individuals.
Strict confidentiality
Authorized release only
Professional and compassionate care
Frequently Asked Questions
Take a proactive step towards your health.
Book a test or speak with our genetic counselors today.
admin@lablog.tech